Corporate Finance Associates Advises Medigistics, Inc. in Sale to Etransmedia Technology, Inc.
Corporate Finance Associates announced that it was the advisor in the acquisition of Medigistics, Inc. by Etransmedia Technology, Inc.
LOS ANGELES, CA, January 25, 2014 /24-7PressRelease/ -- Corporate Finance Associates, an international investment banking services firm providing merger and acquisition, business valuation, capital resource and financiing advisory services, announced that it was the advisor in the acquisition of Medigistics, Inc. by Etransmedia Technology, Inc.
Medigistics, based in Columbus, Ohio, is a full service, multi-specialty medical billing and accounts receivable management solution providing services to physicians and other health care providers in Ohio, Kentucky, Pennsylvania, West Virginia and Michigan. For over 50 years, Medigistics has worked to establish partnerships with the top physician organizations in the communities it serves.
Etransmedia Technology, Inc., headquartered in Troy, NY, is a leading national provider of information solutions to the healthcare industry offering comprehensive software, service and connectivity solutions to simplify critical functions in the healthcare community. The addition of Medigistics' products and services portfolio and geographic reach both broadens and strengthens Etransmedia's positioning in the marketplace.
"It was a distinct pleasure working with Medigistics and Etransmedia. It is always professionally satisfying to see a partnership form where the opportunities for collaboration and growth are so immediately evident", said Robert St. Germain, Managing Director and Principal, CFA Columbus, lead advisor in the transaction.
Disclaimer: If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.